Subscribe
Time-to-thrombectomy and ischemic stroke outcomes, statins vs other LDL-lowering therapies for CV risk reduction, IV fluid resuscitation of shock, and more

JAMA Editor’s Summary

Time-to-thrombectomy and ischemic stroke outcomes, statins vs other LDL-lowering therapies for CV risk reduction, IV fluid resuscitation of shock, and more

Editor's Audio Summary by Mary McGrae McDermott, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the
September 27, 2016
ADVERTISEMENT
Wise-Formerly Transferwise

Time-to-thrombectomy and ischemic stroke outcomes, statins vs other LDL-lowering therapies for CV risk reduction, IV fluid resuscitation of shock, and more

Editor’s Audio Summary by Mary McGrae McDermott, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the September 27, 2016 issue

ADVERTISEMENT
Wise-Formerly Transferwise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.